BRD2 and hepatocellular carcinoma: Using unsupervised clustering, the differential proteomic profiles, before outlier exclusion, failed to clearly discriminate between HCC tumor and NAT samples, as evidenced by a significant overlap of eight tumor samples with NAT samples (Figure 6C).